APPLICATION OF UV-SPECTROPHOTOMETRY FOR THE QUANTITATIVE DETERMINATION OF CAPTOPRIL IN DRUG
DOI:
https://doi.org/10.14739/2409-2932.2014.1.24834Keywords:
spectrophotometrу, validation, quantitative determination, captopril, drug formulationsAbstract
Introduction. In this paper the simple, rapid and sensitive assay method for the quantitative determination of captopril in two new pharmaceutical formulations (suppositories and nasal gel) is proposed. Analysis was performed directly by using zero-order UV spectrophotometry. It is known from the special literature that the chromatographic techniques used for captopril assay require the expensive equipment and are rather time consuming. Therefore UV spectrophotometry is preferable due to its accuracy, sensitivity and simplicity.
The aim of this study was to develop and validate a new, simple, rapid, precise and accurate UV spectrophotometric method for the quantitative determination of captopril in suppositories and nasal gel.
Materials and methods. The objects of the study were the new drug formulations of captopril, namely 0,05 suppositories and 2,5% nasal gel developed by the scientists of The Chair of Technology of Drugs ofZaporozhye State Medical University. Distilled water was used as the solvent, working standard sample of captopril was used as a reference standard. Analytical equipment: spectrophotometer Specord 200, electronic balance ABT-120-5DM, measuring glassware of class A.
Assay procedure: An accurately weighed sample of gel (0,4000 –0,8000 g) or one suppository was dissolved in distilled water and filtered into a volumetric flask (50,00 ml for gel and 250,0 ml for suppository) . Then the solution was brought to the mark with the same solvent and stirred. 1,00 ml of the resulting solution was transferred into a 25,00 ml volumetric flask and brought to the mark with distilled water. Absorbance was measured at a wavelength of 203 nm on the blank of a solvent. The parallel measurement with 1,00 ml of 0,03% captopril standard solution was carried out. The content of active substance was calculated according to standard formulas.
Results. The suggested procedure was successfully applied for the analysis of two new pharmaceutical formulations. The results obtained by applying the proposed method were statistically analyzed. Validation of the method confirmed its proper precision and recovery (for gel: 100,2%, RSD% = 0,572, n = 9; for suppositories: 99,87%, RSD% = 0,420, n = 9), linearity (for gel: r =0,9978, n=6; for suppositories: r =0,9982, n=6) The received parameters enable the developed procedure to be used in quantitative pharmaceutical analysis.
Conclusions. The applicability of the new procedure is well established by the assay the new drug formulations of captopril – 0,05 suppositories and 2,5% nasal gel. The developed UV spectrophotometric method is potentially useful because of its simplicity, rapidity and accuracy. The procedure is valid according to the validation requirements of Ukrainian Pharmacopeia.References
British Pharmacopeia. – Her Majesty’s Stationery Office. – London, 2009.
United States Pharmacopeia 26. – USP Convention Inc. – Rockville, 2007.
Sultana N. Liquid chromatographic method for the simultaneous determination of captopril, piroxicam, and amlodipine in bulk drug, pharmaceutical formulation, and human serum by programming the detector / N. Sultana, M.S. Arayne, S.N. Ali // J. Sep. Sci. – 2013. – Vol. 36 (19). – P. 3176–3183.
Mazurek S. Quantitative determination of captopril and prednisolone in tablets by FT-Raman spectroscopy / S. Mazurek, R. Szostak // J. Pharm. Biomed. Anal. – 2006. – Vol. 40 (5). – P. 1225–1230.
Спектрофотометричне визначення каптоприлу в субстанції / Ю.В. Бурлака, О.А. Тарханова, С.О. Васюк, В.В. Гладишев // Актуальні питання фармац. та мед. науки та практики. – 2011. – Вип. XХІV. – № 1. – С. 17–19.
Державна Фармакопея України. – 1-е вид. – Х. : РІРЕГ, 2001. – 556 с.
Державна Фармакопея України. – 1-е вид. – Х. : Державне підприємство «Науково-експертний фармакопейний центр», 2008. – Доповнення 2. – 2008. – 620 с.
Изучение влияния вида носителя и поверхностно-активных веществ на биофармацевтические свойства суппозиториев с каптоприлом / Абдуллах Жумаа Алмохамад, В.В. Гладышев, А.П. Лисянская, И.Л. Кечин // Актуальні питання фармац. та мед. науки та практики. – 2011. – Вип. XХІY. – № 2. – С. 102–104.
Изучение влияния основ-носителей на интенсивность высвобождения каптоприла из назальных мягких лекарственных форм / В.В. Гладышев, Алмохамад Жумаа Абдуллах, А.П. Лисянская, И.Л. Кечин // Кубанский научный медицинский вестник. – 2013. – № 5. – С. 69–73.
Державна Фармакопея України. – 1-е вид. – Х. : РІРЕГ, 2001. – Доповнення 1. – 2004. – 520 с.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
